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Introduction
Mast cells are mobile, bone-marrow-derived, granule-con-taining immune cells that are found in all connective tis-
sue and mucosal environments, and in the peripheral and cen-
tral nervous systems (Purcell and Atterwill, 1995; Silver et al.,
1996). Following activation by immunologic or non-immuno-
logic stimuli, mast cells release via their granules a range of
pre-formed mediators, including cytokines, vasoactive
amines, and enzymes. At the light microscope level, the secre-
tory granules of mast cells give a characteristic metachromatic
staining pattern with toluidine blue. Typical histological sec-
tions stained with toluidine blue give the impression that mast
cells are rounded (Fig. 1); however, when they are examined
by transmission electron microscopy or immunohistochem-
istry, a more stellate or dendritic character becomes evident
(Kaminer et al., 1991; Walsh et al., 1991c).
Mast cells are found in all tissues of the oral cavity, inclu-
ding the dental pulp (Farnoush, 1984; Walsh et al., 1995). In
dental pulp, their presence is more difficult to detect, because
tissue injury and neuropeptide release during removal of the
dental pulp elicits degranulation, making the cells difficult to
see by traditional staining approaches based on histochemistry
(Farnoush, 1984). In contrast, both immunohistochemical
detection of mast cell granule proteases and transmission elec-
tron microscopy are able to demonstrate degranulated mast
cells that would otherwise elude detection (Kaminer et al.,
1991).
Mast Cell Mobility
In oral mucosa and skin, mast cells are distributed preferential-
ly about the microvascular bed, close to the basement mem-
branes of blood vascular endothelial cells and nerves (Walsh et
al., 1990a,c) (Fig. 2). This localization of mast cells in both nor-
mal and inflamed sites results from their interaction with the
laminin component of neural and vascular basement mem-
branes via the a6/b1 integrin (CD49f), that serves as a specific
laminin receptor (Walsh et al., 1991a; Zhao et al., 1998). Because
adhesion of mast cells to laminin-containing basement mem-
branes in vivo is influenced by down-regulation of this receptor
during degranulation, mast cells should be recognized as a
mobile cell population, capable of migration within tissues.
Direct assessment of mast cell positioning in normal and
inflamed tissues has demonstrated the plasticity of the mast
cell network (Walsh et al., 1991a; Zhao et al., 1997). The physical
movement of degranulating mast cells away from endothelia
and away from laminin has been documented (Walsh et al.,
1991a), and in this context, the ability of mast cell proteases to
induce stromelysins that degrade laminin (Welle, 1997) has
direct relevance.
A key mediator that influences mast cell migration is mast
cell growth factor (MGF). This molecule can be synthesized by
endothelial cells (Weiss et al., 1995) and epidermal ker-
atinocytes (Kligman and Murphy, 1996), and is thought to
direct the homing of mast cell precursors to epithelial tissues.
Of note, MGF expression is not altered by degranulation of
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mast cells (Weiss et al., 1995). Alterations in the production of
mediators such as MGF and RANTES (regulated on activation
normal T-cell expressed and secreted) may underlie diseases
such as urticaria pigmentosum, in which mast cell traffic is
altered (Lazarus et al., 1991), resulting in intense accumulation
of mast cells in the dermis of the skin (Mirowski et al., 1990;
Walsh et al., 1991a).
The significance of the distribution of mast cells in tissue
compartments relates to the potential for mast-cell-derived
mediators to influence nearby cells, with resulting stimulatory,
inhibitory, or toxic effects. Because degranulation of mast cells
can be induced by a range of stimuli (Table 1), mast cells pro-
vide a common pathway for the development of inflammation
both in the oral cavity and in other sites.
Of particular importance in this regard is the contribution of
neuropeptides. As will be discussed further below, the neu-
ropeptides substance P and calcitonin gene-related peptide
(CGRP) stimulate mast cell degranulation and cause cytokine
release in vitro, and such mediators are implicated in the ongoing
degranulation that is a feature of chronic inflammation at both
the light (Walsh et al., 1995) and electron microscope levels
(Jontell et al., 1986). There is strong evidence for functional inter-
actions between mast cells and nerves (Blennerhassett et al., 1991;
Walsh et al., 1991b; Marshall and Waserman, 1995; Theoharides,
1996), and spatial interactions between mast cells and nerves
have been characterized in skin (Church et al., 1989; Walsh et al.,
1991a; Murphy, 1993; Pujic et al., 1998), oral mucosa (Walsh et al.,
1990c; Zhao et al., 1997; Bartold et al., 2000), and in the respirato-
ry, urogenital, and gastrointestinal tracts (Heine and Forster,
1975; Skofitsch et al., 1985; Bienenstock et al., 1987; Stead et al.,
1989; Ferrante et al., 1990; Myers et al., 1991; Undem et al., 1995).
Mast Cell Mediators
Following degranulation, mast cell mediators are deposited in
large quantities in the extracellular environment, where they
exert effects on endothelial cells and other cell types. Mast cells
may subsequently synthesize and secrete additional mediators
that are not pre-formed in their granules. Key mediators that
are pre-formed in mast cells are the serine proteases tryptase,
chymase, and cathepsin G (Irani et al., 1986), histamine,
heparin, serotonin (Soter and Austen, 1976), acid hydrolases
(Stevens and Austen, 1989), and the cytokines tumor necrosis
factor-a (TNF) (Walsh et al., 1991b) and interleukin-16 (Galli,
1993) (Fig. 3). Following activation, mast cells can synthesize a
range of mediators, including the interleukins IL-1, IL-3, IL-4,
IL-5, IL-6, IL-8, IL-10, IL-13, and IL-16, together with granulo-
cyte-macrophage colony-stimulating factor (GM-CSF), platelet-
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Figure 1. Characteristic morphology and perivascular location of a
mast cell (arrow), as seen in a one-micrometer-thick resin section
stained with toluidine blue. The mast cell is close to the abluminal sur-
face of the endothelium of this post-capillary venule. The basal
epithelial layer (E) is seen in the upper right. Original magnification
X1000. Scale bar indicates 5 mm.
Figure 2. Triple-immunoperoxidase-labeled frozen section showing the
relationship among mast cells, blood vessels, and nerves. Peripheral
nerves stained with antibodies to neurofilament protein are brown,
while the CD31 (PECAM-1) adhesion molecule on the luminal surface
of the blood vessel is stained pink. Tryptase in mast cells is stained
black. Several mast cells are present in the section. Two of these (indi-
cated by arrows) are juxtaposed between nerves and blood vessels.
Original magnification X400. Scale bar represents 20 mm.
TABLE 1
Selected Mast Cell Secretagogues
Activators of the surface high-affinity IgE Fc receptor
• Antigens
• Anti-Ig E
Neuropeptides
• Substance P (Matis et al., 1990; Walsh et al., 1990a;
Cocchiara et al., 1995)
• Calcitonin gene-related peptide (Piotrowski and Foreman,
1986)
Chemokines
• RANTES (Zhao et al., 2002a)
Calcium ionophores
• Ionophore A23187 (Kaminer et al., 1991)
• Compound 48/80 (Kaminer et al., 1991)
Medications
• Morphine sulfate (Klein et al., 1989; Walsh et al., 1991b)
Physical factors
• Cold temperatures—in cold dermographism (Murphy et al.,
1987)
• Ultraviolet B radiation, via cis-urocanic acid (Walsh, 1995;
Wille et al., 1999)
• Exercise—in exercise-induced anaphylaxis (Sheffer et al., 1985)
activating factor (PAF), RANTES, macrophage inflammatory
protein (MIP-1a), and the arachidonic acid metabolites
prostaglandin 2 and leukotriene C4 (reviewed in Galli, 1993;
Sutton and Gould, 1993; Kobayashi et al., 2000; Zhao et al.,
2002b). Autocrine and paracrine cytokine regulatory networks
influence mast cell synthesis of mediators. For example, IL-5
provides an autocrine influence by promoting the secretion of
TNF, IL-5, IL-13, MIP-1a, and GM-CSF after mast cell degranu-
lation, without increasing histamine release (Ochi et al., 2000),
while TNF can increase mast cell secretion of IL-8 (Abraham
and Arock, 1998).
Each mast cell typically contains between 80 and 300 gran-
ules (Eady, 1976). When activated, mast cells may either under-
go explosive degranulation and then re-synthesize their gran-
ules (Chakravarty, 1983), or they may release solitary granules
into their environment on an ongoing basis, a process termed
'piecemeal degranulation' that has been observed in both the
oral mucosa (Walsh et al., 1995) and skin (Kaminer et al., 1991).
Even under conditions of rapid, anaphylactic degranulation,
some granules within mast cells show gradual 'piecemeal'
release, with micro-vesicular transport of pieces of granules to
the cell surface (Kaminer et al., 1995).
Ultrastructurally, the granules in mast cells of the oral
mucosa and skin have a complex form, with amorphous
regions located next to crystalline regions. The latter show a
range of configurations, such as scrolls, lattices, and gratings
(Kaminer et al., 1991). Immuno-electron microscopy has con-
firmed that the key mediators of chymase, tryptase, TNF, and
cathepsin G are packaged separately within the granules
(Walsh et al., 1991b; Whitaker-Menezes et al., 1995).
Mast Cell Proteases
The historical distinction of mast cell populations in tissues into
"connective tissue" and "mucosal" phenotype relates to their
tinctorial properties, which reflect the nature of the charged
molecules found within mast cell granules. The expression of
mast-cell-specific serine proteases (tryptase and chymase) is the
current "gold standard" for determining mast cell phenotypes in
various tissue compartments (Irani et al., 1986; Kaminer et al.,
1991). Thus, "mucosal" mast cells with granules containing
scroll-like structures are reactive with antibodies directed
against tryptase but not chymase (MCT), whereas "connective
tissue" mast cells with granules containing lattice or grating-like
structures express both tryptase and chymase (MCTC).
These two mast cell subpopulations show important differ-
ences with respect to intracellular stores of mediators, responses
to secretagogues, and sensitivities to cytokines that promote mast
cell differentiation. Thus, an evaluation of mast cell phenotype is
critical to an understanding of the contributions of mast cells in
different sites. In human oral mucosa and dental pulp, the pre-
dominant mast cell population is MCTC (Walsh et al., 1990c, 1995).
MCTC in general contain stores of histamine and TNF that exceed
those of their MCT counterparts (Walsh et al., 1990c).
Tryptase is a trypsin-like proteinase that is found in the
granules of both mast cells and basophils (Schwartz et al., 1985,
1987; Craig et al., 1988). Major functional activities of mast cell
tryptase include serving as a mitogen for epithelial repair, and
facilitating the recruitment of granulocytes by inducing
epithelial cell secretion of IL-8 (Caughey, 1994; Welle, 1997).
Mast cell tryptase can contribute to connective tissue break-
down by activating pro-collagenase directly (Gruber et al.,
1988), and by setting in motion a cascade of matrix metallo-
proteinases (MMP) by activating prostromelysin-1 to
stromelysin (Gruber et al., 1989). Breakdown of the connective
tissue matrix induced by mast cell tryptase may facilitate the
infiltration of tissues by leukocytes during the development of
inflammation.
Chymase is a mast-cell-specific mediator that is not found
in basophils. Chymase can function as an IL-1b convertase,
cleaving inactive precursor IL-1b to yield the active molecule
(Kupper et al., 1990). This has direct relevance to inflammation
in terms of mucosal inflammation, where the IL-1b precursor
may be secreted by activated keratinocytes (Walsh et al.,
1990b,c). Chymase also contributes to a negative feedback con-
trol mechanism for neurogenic activation of mast cell secretion,
since chymase (but not tryptase) can degrade substance P,
CGRP, and other neuropeptides, and thereby interrupt axon-
reflex-mediated neurogenic inflammation (Caughey et al., 1988;
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Figure 3. Stained cytocentrifuge preparations of purified mast cells, showing metachromatic staining of the granules with toluidine blue (panel
A). Immunohistochemical staining reveals the presence of both chymase (panel B) and TNF (panel C) in the mast cell granules. Original mag-
nification X1000. Scale bar indicates 5 mm.
Welle, 1997).
Mast-cell-derived chymase and tryptase are
thought to play a role in the breakdown of base-
ment membrane structural proteins in conditions
such as oral lichen planus (Zhou et al., 2002).
Enzymatic disruption of the epithelial basement
membrane may facilitate the migration of cyto-
toxic CD8+ T-lymphocytes into the epithelium
through breaks in type IV collagen created by
tryptase (Zhao et al., 2002b). Both tryptase and
chymase activate matrix metalloproteinase 3
(MMP-3), and indirectly activate pro-collagenase
(pro-MMP-1) (Welle, 1997). Since MMP-3 is a
stromelysin that cleaves type IV collagen and
laminin, enhanced expression of MMP-3 in
inflammatory lesions will facilitate degradation
of the extracellular matrix (Gruber et al., 1989;
Lees et al., 1994). Direct evidence exists for
enhanced expression of MMP-3 in the epithelium
overlying degranulated mast cells in oral lichen
planus (Zhou et al., 2001). Mast-cell-derived TNF
has also been implicated as a major stimulant of
T-lymphocyte secretion of the gelatinase MMP-9 in the same
condition (Zhou et al., 2001). MMP-9 cleaves type IV collagen,
which again would facilitate the migration of leukocytes
between tissue compartments.
Changes in epithelial basement membranes induced by
mast cell proteases may have an impact on the population of
Langerhans cells (LC) in the overlying epithelium. Phenotypic
transformation of dermal macrophages to LC in vivo has been
documented (Murphy et al., 1986), and the reconstitution of
epidermal LC from dermal cells requires focal disruptions of
the epidermal basal lamina (Murphy et al., 1985). As will be dis-
cussed further below, the process of development of LC from
macrophage precursors can be promoted by TNF (Sueki et al.,
1993; Anasthanas-Platsis et al., 1995), again implying a contrib-
utory role for mast cells in this process.
Mast Cell Histamine
Mast-cell-derived histamine mediates important changes in
vascular permeability via structural changes in the microvascu-
lar endothelium, such as endothelial contraction and intercel-
lular gap formation (Majno and Palade, 1961). In addition, his-
tamine promotes the adhesion of platelets by mobilizing the
adhesion molecule P-selectin (CD62P, GMP-140) from Weibel-
Palade bodies to the luminal surfaces of endothelial cells
(Johnson et al., 1989). In a recently developed microplate hista-
mine assay, direct evidence for histamine release from oral
mucosal mast cells has been presented (Zhao et al., 2001).
Mast-cell-derived histamine is responsible for wheal for-
mation in the classic triple response. The effects of histamine in
this response are amplified, but not mimicked, by mast cell
chymase, via a pathway involving the H1 histamine receptor
(Rubinstein et al., 1990). This suggests that when mast cells of
the MCTC phenotype degranulate, the vasoactive effects of his-
tamine may be modulated by the chymase that is delivered
from the same mast cell granules.
Mast Cell TNF
Considerable attention has been directed toward the contribu-
tion of mast-cell-derived TNF in inflammation. Mast-cell-
derived TNF induces endothelial expression of E-selectin
(CD62E, ELAM-1) (Walsh et al., 1991b). Studies using neutral-
izing antibodies have shown that for the "connective tissue"-
type mast cells (MCTC) that predominate in the oral cavity and
skin, TNF is the sole mediator responsible for the induction of
E-selectin (Walsh et al., 1991b). E-selectin is critical for the rapid
adhesion of neutrophils, T-lymphocytes, monocytes, and other
leukocytes to endothelial cells (Bevilacqua, 1993).
In oral inflammatory lesions, degranulation of mast cells
can be identified by externalization of granules and depletion
of intracellular stores of mediators, as determined by toluidine
blue staining and chymase immunohistochemistry. At the
ultrastructural level, the pattern of granule enlargement, lucen-
cy of granule matrices, and fusion of granules is typical of
chronic or piecemeal degranulation (Jontell et al., 1986; Walsh et
al., 1995).
Chronic synthesis and release of TNF from mast cells may
maintain leukocyte migration and promote chronicity in
inflammatory lesions, as has been shown in oral lichen planus
(Walsh et al., 1990c, 1995). TNF exerts modest chemotactic
effects on neutrophils; however, its major effects are mediated
through its effects on adhesion molecule expression. Through
the latter effects, mast cell TNF can orchestrate the migration of
neutrophils and T-lymphocytes into tissues (Walsh et al., 1990a;
Waldorf et al., 1991). A clear causal relationship among mast cell
degranulation, TNF release, and the development of inflam-
mation in the oral mucosa and skin has been documented in
vitro, by both immunological and non-immunological stimuli
(Klein et al., 1989; Walsh et al., 1991b; Walsh, 1995), and the same
pathways have been demonstrated in vivo (Waldorf et al., 1991;
Walsh and Murphy, 1992a; Walsh, 1995). These studies provide
a clear explanation and a molecular mechanism for earlier
observations that linked mast cell degranulation with the initi-
ation of inflammation and the development of chronic inflam-
mation (Jontell et al., 1986; Kowalski and Kaliner, 1988).
In addition to the stimulatory effects of mast-cell-derived
TNF on endothelium, TNF exerts a range of effects on other cell
types (Table 2). A major target of interest in the oral cavity is the
keratinocyte. At low concentrations, TNF can arrest the growth
of keratinocytes, while high concentrations are cytotoxic
(Philip and Epstein, 1986; Walsh et al., 1990c; Sugerman et al.,
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TABLE 2
Selected Biological Effects of TNF
Target Cell Effect
Endothelial cells Secretion of IL-1 and IL-6
Expression of adhesion molecules CD62E, CD54, and CD106
Keratinocytes Cytostatic and cytotoxic
Secretion of IL-6, IL-8, and GM-CSF
Expression of CD54
Langerhans cells Induction of CD1a and HLA-DR
Chemoattraction
Accumulation in draining lymph nodes
T-lymphocytes IL-2 receptor expression
IFN-g secretion
Increased binding to fibronectin
Macrophages Secretion of IL-1, IL-6, GM-CSF, and CSF-1
Enhanced TNF-a release
Based on Seymour et al. (1995) and Sugerman et al. (1996).
1996). Prolonged release of TNF from mast cells has been impli-
cated in stem cell damage and epithelial injury in oral lichen
planus (Walsh et al., 1990c) and chronic graft-vs.-host disease
(Murphy et al., 1994). Because TNF can induce cytotoxic T-lym-
phocyte differentiation (Robinet et al., 1990), and can enhance
the cytotoxicity mediated by monocytes and other cell types
(Ostensen et al., 1987), mast-cell-derived TNF can play an
important role in augmenting cytotoxic responses that are
mediated by other cell types. While mast cells and basophils
are the only cells capable of storing and releasing pre-formed
TNF (Walsh et al., 1991b), it is important to bear in mind that
other cell types in inflammatory lesions can make considerable
contributions to local TNF production. Such cells include
macrophages, Th1 T-lymphocytes, endothelial cells, and ker-
atinocytes (Walsh et al., 1995; Sugerman et al., 1996).
A second major target for mast-cell-derived TNF is the T-
lymphocyte. Recent studies have demonstrated that, in oral
lichen planus, TNF induces lesional T-cells to secrete the
chemokine RANTES, which then is able to stimulate mast cell
degranulation, with the accompanying secretion of histamine
(Zhao et al., 2002a). This positive feedback mechanism provides
an explanation for how T-lymphocytes in the infiltrate are able
to promote a chronic pattern of mast cell degranulation and
TNF secretion (Walsh et al., 1990c, 1995). It has been suggested
that the expression of RANTES and its receptor (CCR1) on pop-
ulations of mast cells and T-lymphocytes may prolong the sur-
vival of these cell types and thus promote the development of
chronic inflammation (Zhao et al., 2002a). Nevertheless,
because of the plethora of cytokines and chemokines that can
serve as paracrine signals, inflammatory reactions that are dri-
ven by interactions between mast cells and T-lymphocytes
have a high degree of redundancy, and a contribution from
other mediators is likely.
In addition to the influences described above, mast-cell-
derived TNF can exert a range of effects on other cells (Table 2).
Of immediate interest in the context of inflammation in the oral
cavity are the following TNF effects: activation of Langerhans
cells (LC) (Ishii et al., 1990; Ioffreda et al., 1993), stimulation of
LC precursors (Anasthanas-Platsis et al., 1995), activation of
perivascular dendritic cells (Walsh et al., 1991c; Sueki et al.,
1993), and inhibition of epithelial cell proliferation (Walsh et al.,
1990c; Sugerman et al., 1996). Thus, chronic synthesis and
release of TNF from mast cells can be recognized as an impor-
tant factor in promoting chronicity of inflammation. While
these pathways have been studied in most detail for oral lichen
planus, there is opportunity to apply similar concepts to other
inflammatory conditions of the oral mucosa and skin (Walsh
and Murphy, 1992a; Sugerman et al., 2000).
Mast Cell IL-1 and IL-4
Activated mast cells can secrete both Interleukin-1 (IL-1) and
Interleukin-4 (IL-4), although neither is present as a pre-formed
mediator in MCTC (Burd et al., 1989; Klein et al., 1989). Since
activation of mast cells (following degranulation) is implicated
as a stimulus for mast cell IL-1 production, mast-cell-derived
chymase, which is deposited in the extracellular environment
following degranulation (Kaminer et al., 1991; Waldorf et al.,
1991), is placed ideally to activate released IL-1b.
IL-1 can be synthesized by macrophages and monocytes in
response to endotoxin from Gram-negative anaerobes, such as
those implicated in pulpal and periapical pathology (Walsh et al.,
1989). Because such synthesis and release take from 6 to 24 hours
to occur, IL-1 secreted by macrophages (or activated mast cells)
is unlikely to serve as a "primary" mediator in the chronological
sense, in that its effects will likely follow those of TNF. It should
be noted that TNF is more potent and results in more rapid and
stronger expression of E-selectin than IL-1 (Pober et al., 1985;
Bevilacqua, 1993). In the dental pulp, release of TNF from mast
cells would be a key early event in eliciting a neutrophil influx
into the dental pulp. However, at subsequent timepoints, IL-1
secreted by mast cells or macrophages would contribute to sus-
tained activation of the microvascular endothelium.
IL-4 secreted by activated mast cells is likely to influence
inflammation in terms of the progression from acute to chronic
inflammation. IL-4 primes endothelium for adhesion of lym-
phocytes and monocytes, and suppresses adhesion of neu-
trophils (Patel, 1999; Kotowicz et al., 2000). These changes are
mediated by fluctuations in the adhesion molecule repertoire of
endothelial cells, viz. suppression of E-selectin and P-selectin,
and induction of vascular cell adhesion molecule 1 (VCAM-1,
CD106) (Walsh and Murphy, 1992a; Gemmell et al., 1993; Patel,
1999). Because CD106 binds strongly to lymphocytes, but only
weakly to monocytes and not to granulocytes (Osborn et al.,
1989), chronic synthesis and release of IL-4 from mast cells
would promote a transition from acute to chronic inflammation.
Other molecules involved in leukocyte adhesion to
endothelial cells include CD31 (PECAM-1) and CD54 (ICAM-
1). These molecules stabilize leukocyte attachment to endothe-
lia to permit trans-endothelial migration (Bevilacqua, 1993).
Fluctuations in the expression of these molecules in inflamma-
tion have been observed and have been linked potentially with
release of cytokines including TNF, IL-1, and IL-4 from mast
cells and other cell types (Walsh and Murphy, 1992a; Gemmell
et al., 1993).
Interactions between Mast Cells and 
Other Immune Cell Types
Through the release of mediators, mast cells can exert potent
chemotactic and stimulatory effects on other cell types, such as
macrophages and neutrophils (Ming et al., 1987). Likewise,
mast-cell-derived mediators may affect connective tissue cells
and extracellular matrix, and thereby influence wound healing
and repair (Walsh and Murphy, 1992a). Interactions between
mast cells and other cell types are reciprocal, in that certain
mediators produced by endothelial cells and "resident" perivas-
cular macrophages, viz. interleukins 1 and 8, can potentiate or
inhibit mast cells' histamine release.
Antigen Presentation
An important interaction between mast cells and other cell
types is that of antigen presentation to T-lymphocytes. Mast
cells express both MHC class I and class II molecules (Love et
al., 1996; Malaviya et al., 1996), as well as the CD80 (B7-1), CD86
(B7-2), and CD54 molecules that serve as the second signal for
T-lymphocyte activation during antigen presentation (Frandji
et al., 1996). They are also able to process endogenous viral and
bacterial antigens for MHC class-I-restricted presentation to T-
cells (Malaviya et al., 1996). While mast cells are not 'profes-
sional' antigen-presenting cells, the antigen presentation and
co-stimulatory signals delivered by mast cells may contribute
to the development of a specific T-lymphocyte response in the
induction phase of inflammation, in conditions such as oral
lichen planus (Zhao et al., 2002b). Mast cells share a strategic
perivascular location with dendritic antigen-presenting cells
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(Walsh et al., 1991c), and their production of cytokines in this
location may be equally as important as the expression of
accessory molecules on their cell surfaces.
Mast cells are able to contribute to the innate immune
response to microbial infection, and this is of critical impor-
tance in the response to helminths. Recent studies have
revealed that mast cells can bind a range of bacteria in the gas-
trointestinal tract in the absence of antibody or other host-
derived opsonins (reviewed in Abraham and Arock, 1998).
Mast cells can phagocytose and kill microbes, and also present
bacterial antigens. Despite the importance of these roles in the
gastrointestinal tract, they appear to be of little or no relevance
in the oral cavity.
Mast Cell Influences on T-lymphocytes
Because mast cells have a long lifespan and can produce a large
panel of cytokines, it is plausible that they could positively
influence the survival of T-lymphocytes. This is of particular
relevance given the perivascular clustering of lymphocytes that
occurs in many inflammatory lesions in the oral mucosa
(Wynne et al., 1988). Mast-cell-derived IL-6 and TNF have been
shown to provide alternative co-stimulatory survival signals to
CD8+ T-lymphocytes, in the absence of the usual B7-CD28 and
IL-2 co-stimulatory pathways (Sepulveda et al., 1999). This pos-
itive influence on survival is thought to have direct relevance to
disease chronicity in oral lichen planus (Zhao et al., 2002b), and
may explain the limited T-cell receptor repertoire of lesional T-
lymphocytes in that condition (Zhou et al., 1996).
Mast cells are able to exert an influence on the migration of
T-lymphocytes at several junctures: the endothelium (via
enhanced adhesion molecule expression), the extracellular
matrix (directly through proteases, and indirectly through the
induction of gelatinases and stromelysins), and within tissue
compartments (via chemotaxis). In addition to mast cell IL-8
(Moller et al., 1993), mast-cell-derived lymphotactin can serve
as a chemo-attractant for CD8+ T-lymphocytes, and mast-cell-
derived IL-16 is a chemoattractant for CD4+ T-lymphocytes
(reviewed in Zhao et al., 2002b). Anchorage signals for T-lym-
phocytes can be provided by mast cell CD54, RANTES, and
TNF (Franitza et al., 2000).
Mast Cells and the Neural-immune Network
As already mentioned, there is a well-known spatial affinity
between mast cells and nerves in mucosal tissues of the gas-
trointestinal tract (Stead et al., 1989), mesentery (Skofitsch et al.,
1985), and airways (Undem et al., 1995), as well as in the
bronchial ganglia (Myers et al., 1991) and meningeal mem-
branes (Ferrante et al., 1990). Close approximations between
mast cells and nerves have been documented in human skin
(Walsh et al., 1991a; Pujic et al., 1998), human oral mucosa
(Walsh et al., 1990c; Zhao et al., 1997), and rat palatal mucosa
(Matsson et al., 1995).
The results of studies that have failed to find any mast-
cell/nerve interactions in normal buccal mucosa (Ruokonen et
al., 1993) can be explained by technical factors, in that such stud-
ies used toluidine blue staining to identify mast cells. This
method is less sensitive than the immunohistochemical local-
ization of mast cells by anti-tryptase antibodies, and underesti-
mates the total number of mast cells as well as the number of
degranulated mast cells (Zochodne et al., 1994). The preferred
method in the author's laboratory is a sensitive double- or
triple-labeling immunohistochemical technique that allows for
the co-localization of two or three antigens in frozen tissue sec-
tions (Zhao et al., 1997; Pujic et al., 1998), since this is believed to
result in an accurate assessment of mast-cell/nerve interactions.
Useful markers to reveal the delicate neural plexus include neu-
rofilaments, neural cell adhesion molecule, neuropeptides, and
nerve-cell-specific clathrin (reviewed in Egan et al., 1998).
The spatial association of nerves and mast cells facilitates
the effects of neuropeptides that are secretagogues for mast
cells. In an organ culture system, neuropeptides found in den-
tal pulp nerves (substance P [SP] and calcitonin gene-related
peptide [CGRP]) have been shown to cause degranulation of
dental pulp mast cells, and thereby to elicit the induction of E-
selectin and the up-regulation of CD54 on post-capillary venu-
lar endothelium in the sub-odontoblastic plexus (Gentner et al.,
1996; Thomas and Walsh, 1997). SP and CGRP often co-exist in
nerve fibers (Gibson et al., 1984; Lundberg et al., 1986) and fre-
quently are released simultaneously (Saria et al., 1986; Payan et
al., 1984). As well as inducing degranulation of mast cells
(Piotrowski and Foreman, 1986), CGRP inhibits the degrada-
tion of SP (Le Greves et al., 1985).
SP and CGRP are important mediators in neurogenic
inflammation, and both are present in considerable quantities
in nerves within the oral cavity (Wakisaka, 1990). SP is associ-
ated with numerous biological events, ranging from bron-
choconstriction, nociception, and plasma extravasation to neu-
rogenic inflammation. In the dental pulp, stimulation of type A
nerve fibers results in increased pulpal blood flow and perme-
ability of microvessels. This increased blood flow occurs pre-
dominantly via axon reflexes rather than by the direct action of
vasomotor nerves. Antidromic stimulation leads to release of
SP, which promotes vasodilation and inflammation. In con-
trast, CGRP plays a lesser role in neurogenic inflammation in
the oral cavity than in the skin (Payan, 1992).
A major pathway for SP-mediated inflammatory responses
is the mast cell. For exploration of the actions of SP on mast
cells in human dental pulp, a useful experimental approach has
been to obtain tissues from extracted third molars, and main-
tain these in short-term organ culture in the presence of SP or
SP agonists. SP agonists include septide ([pGlu6, Pro9]-sub-
stance P [6-11], an NK-1 selective agonist) and senktide (suc-
cinyl-[Asp6, N-Me-Phe8]- substance P [6-11], an NK-3 selective
agonist). In these studies, endothelial E-selectin expression was
found to be increased following treatment with either SP or
septide, whereas in senktide-treated pulp tissue, expression
was very weak, and was not different from that in control sam-
ples maintained in medium alone. This indicates that the
SP/mast-cell/endothelial response of E-selectin expression is
mediated through the NK-1 receptor expressed on dental pulp
mast cells, rather than by other classes of tachykinin receptor
(Thomas and Walsh, 1997). This is consistent with the known
role of SP and mast cells in neurogenic inflammation in the skin
(Matis et al., 1990; Payan, 1992).
It has been suggested that mast cell degranulation in
response to release of neuropeptides is a key event in the
immunopathogenesis of oral lichen planus (Walsh et al., 1990c).
Formal analysis of spatial interactions between mast cells and
nerves in normal oral mucosa and oral lichen planus by dou-
ble-labeling techniques indicates that the density of mast cells
is greater by two-fold in lichen planus than in normal buccal
mucosa. Moreover, the frequency of spatial associations
between nerves and mast cells is twice as high in lichen planus
(Zhao et al., 1997). The most superficial region of the lamina
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propria is the area with the highest number of interactions with
nerves, as predicted earlier (Walsh et al., 1990c).
Useful parallels can be drawn between the physical
arrangement of mast cells in the sub-odontoblastic plexus of
the dental pulp and their positioning in the lamina propria of
the oral cavity and in the superficial dermis of the skin. In all
three sites, the mast cells form a network that places them close
to neural elements ('upstream') and to post-capillary venular
endothelium ('downstream'). The downstream events (release
of TNF, histamine, serine proteases, etc.) have been studied
intensively for many years (Walsh et al., 1990a; Walsh and
Murphy, 1992a), and the phenomenon of activation of endothe-
lial cells induced by mast cells has been characterized in detail
(Klein et al., 1989; Matis et al., 1990; Walsh et al., 1991b).
More recently, attention has turned to the 'upstream' side,
specifically how mast cells may interface with other cells to
form a 'neural-immune network' (NIN). That such a network
should exist in oral mucosa and skin is not surprising, given
that close apposition between immune cells and nerves has
been shown in other tissues—for example, in the spleen (Felten
et al., 1987). The genesis of the NIN concept was mapping stud-
ies that used multiple labeling to determine the spatial interac-
tions between mucosal and cutaneous nerves and cells of the
immune system. Close approximations of vertically ascending,
unmyelinated nerve fibers with mast cells and Langerhans cells
(LC) were demonstrated, initially in human skin (Walsh and
Murphy, 1992b; Murphy, 1993; Hosoi et al., 1993; Walsh et al.,
1996; Pujic et al., 1998) and subsequently in primate and murine
skin (Egan et al., 1998) and human oral mucosa (Bartold et al.,
2000). Of note, these nerves did not come into contact with
stem cells, Merkel cells, or melanocytes, but rather were con-
fined to the LC, immune surveillance cells that form a complex
three-dimensional network by means of their extensive den-
drites that traverse intercellular spaces between keratinocytes.
These studies confirmed that the formation of spatial interac-
tions of mast cells and LC with these nerve fibers was not a
chance phenomenon. Both mast cells and LC are highly mobile
cell populations, while nerves are stationary elements within
tissues. The existence of trophic effects was suggested by the
alignment of newly arrived LC and mast cells with these same
nerve fibers (Walsh et al., 1996). The occurrence of neuropep-
tides such as CGRP, both in nerve fibers and on the cell surface
of LC, is functionally relevant, as demonstrated by effects of
CGRP on LC function (Hosoi et al., 1993; Asahina et al., 1995).
The dynamic and specific nature of the nerve-LC interac-
tion was demonstrated by two different experimental
approaches: by studying regeneration of the epithelial LC-
neural plexus following ablation of LC during allogeneic bone
marrow transplantation in humans (Walsh et al., 1996), and by
evaluating changes in the expression of protein gene product
9.5 by epidermal LC following transection of the sciatic nerve
in rats, and its subsequent re-innervation (Hsieh et al., 1996).
The same nerves that come into contact with LC were
shown to form close associations with mast cells (MCCT) (Walsh
and Murphy, 1992b; Murphy, 1993; Egan et al., 1998; Pujic et al.,
1998), and this raises the intriguing issue of the function of the
LC/mast-cell connection, in the context of immune surveil-
lance.
Several investigations have shed light on this issue. Studies
of the sunburn response from short-wavelength ultraviolet B
(UVB) radiation have revealed that UVB, both in vitro and in
vivo, induces degranulation of cutaneous mast cells, with
release of TNF and serine proteases, and subsequent induction
of E-selectin on microvascular endothelium (Walsh, 1995).
Removal of the epidermis and the use of dermal explants main-
tained in organ culture confirmed that all TNF released was
derived from mast cells in the superficial dermis (Walsh, 1995).
UVB is also known to impair the induction phase of delayed-
type hypersensitivity (DTH) in particular strains of mice by a
mechanism triggered by cis-urocanic acid, which is dependent
upon TNF (Bacci et al., 1996). Indeed, cis-urocanic acid has been
shown to elicit mast cell degranulation, TNF release, and the
consequential expression of E-selectin on endothelium (Wille et
al., 1999). TNF has been shown to alter LC surface antigen
expression (Ishii et al., 1990), and to alter the LC cytoskeleton by
reducing the expression of vimentin (Bacci et al., 1996). More
recently, TNF has been shown to regulate the migration of LC
from epithelia, causing them to accumulate in draining lymph
nodes (Cumberbatch and Kimber, 1992; Cumberbatch et al.,
2001). Thus, TNF released from mast cells in the response to
acute UVB irradiation is able to alter the function not only of
the endothelium, but also of the overlying LC network. Mast-
cell-driven changes in connective tissue elements such as
fibroblasts have also been described with UVB irradiation
(Kligman and Murphy, 1996).
A second insight into the functional interplay between
mast cells and LC has been gained from studies of DTH in
humans. LC serve as the first line of responder cells in oral
mucosal and cutaneous inflammation. Elegant studies of ultra-
structural events in DTH have demonstrated the ability of LC
to serve as a "messenger" between skin and lymph nodes
(Silberberg et al., 1976). Uptake of antigens or haptens by LC is
known to be an early event in this reaction, and occurs within
1-2 hours of challenge (Shelley and Juhlin, 1976).
The important possibility exists that when LC interact with
antigen, the release of SP or CGRP in the lamina propria or der-
mis elicits mast cell degranulation, with the consequential
events of TNF release and endothelial activation (Murphy,
1993). Mast cell degranulation, as witnessed by ultrastructural
alterations and discharge of pre-formed mediators, also occurs
in the first two hours following challenge (Waldorf et al., 1991;
Walsh et al., 1991b). Mast cells are the only dermal cell type to
display ultrastructural alterations at this juncture. In the ensu-
ing four-hour period, expression of E-selectin on microvascular
endothelium can be observed, and "pioneer"
CD4+/CD45RO+/CD29+ T-lymphocytes begin to form
perivascular aggregates (Waldorf et al., 1991). Mast cells, which
have depleted their stores of TNF by four hours post-challenge,
subsequently express enhanced levels of TNF mRNA, and
resynthesize this pre-formed mediator during the ensuing 24
hours (Walsh et al., 1991b).
It is noteworthy that while these changes precede clinical
evidence of inflammation, they are frequently accompanied by
urtication, a sign tentatively related to neuropeptide release
and mast cell degranulation (Murphy, 1993). More importantly,
the key observation from these studies—that mast cells degran-
ulate at a time when hapten is still within the epidermis—has
until recently lacked any cogent explanation. The existence of a
"neural immune network" (NIN) which links epidermal "sur-
veillance" cells (LC) and dermal regulatory cells (mast cells)
provides an explanation for coordinated LC and mast cell
responses in delayed-type hypersensitivity.
Additional proof of the functional role of the NIN was pro-
vided by studies that compared mast-cell-driven responses in
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human skin in vivo, with an intact NIN, with full-thickness
human skin grafted to immuno-deficient SCID mice. The latter
lacked the unmyelinated axons of the NIN, but otherwise had
intact mast cell and endothelial cell responses (Christofidou-
Solomidou et al., 1996). Mast cell degranulation with chymase
release and endothelial expression of E-selectin were used as
markers of NIN function. Topical application of capsaicin, an
agent that causes explosive release of substance P and other neu-
ropeptides from neural elements, to forearm skin elicited mast
cell degranulation and E-selectin induction, whereas these
events failed to occur in xenografts treated with capsaicin (Egan
et al., 1998). From the foregoing, it can be concluded that neu-
ropeptide release within an intact NIN exerts a functional role in
regulating inflammation in the skin and oral mucosa.
Therapeutic Implications
Based on the concept that mast cells play a critical role in the
induction of inflammation, it is logical to use therapeutic
agents to alter mast cell function and secretion, to thwart
inflammation at its earliest phases. For cutaneous inflamma-
tion, this has been accomplished in vitro and in vivo with the
mast cell stabilizing agent disodium cromoglycate and a relat-
ed compound, proxicromilin (Klein et al., 1989; Walsh et al.,
1990c; Walsh, 1995). Abrogation of inflammation by first pur-
ging the challenge site of granulated mast cells with the secret-
agogue compound 48/80 or by depletion of neuropeptide (sub-
stance P, CGRP) stores with the agent capsaicin has also been
reported (Payan et al., 1984). Blockade of dental pulp mast cell
responses in vitro has been achieved with neutralizing antibod-
ies to TNF (Gentner et al., 1996), and with substance P receptor
antagonists (Thomas and Walsh, 1997). Similarly, neutralizing
anti-TNF antibodies have been shown to abrogate mast-cell-
driven graft-vs.-host disease in both murine and human sys-
tems (Herve et al., 1992; Murphy et al., 1994).
An additional stratagem is the use of soluble receptors to
inactivate the TNF released from mast cells. The p55 and p75
soluble TNF receptors can compete with cell-bound receptors
for binding TNF, and can bind directly to TNF to block its bio-
logical activity (Engelmann et al., 1990; Leeuwenberg et al.,
1994). Accordingly, it has been suggested that soluble TNF
receptors applied locally may abrogate the pro-inflammatory
effects of TNF (Sugerman et al., 1996).
Corticosteroids have been utilized for decades in the treat-
ment of inflammatory conditions of the dental pulp and oral
mucosa. An important property of corticosteroids that may
contribute to their therapeutic efficacy is their ability to deplete
mast cells locally at sites of prolonged or occlusive application
(Lavker and Schechter, 1985). Corticosteroids have been used
successfully to deplete mast cells in the treatment of the cuta-
neous mast cell disease urticaria pigmentosum (Barton et al.,
1985); however, the side-effects of intense therapy with topical
steroids (such as epithelial atrophy) limit the usefulness of this
therapeutic approach (Walsh et al., 1990a).
Conclusions
Mast cells serve a critical role in the development of inflamma-
tion in the oral mucosa and the dental pulp, both in the early,
vaso-inductive events and in the transition from acute to chron-
ic inflammation. Because of the unique properties of mast cells,
these cells are ideally poised to serve as "gatekeepers" of the
microvasculature in the oral cavity. An appreciation of the mul-
tiple interactions among mast cells, endothelial cells, nerves,
and other cells of the immune system provides a basis for ther-
apies for targeting mast cell responses. In the future, it may be
possible to develop novel approaches that influence the release
of pro-inflammatory molecules or neuropeptides to ameliorate
mast-cell-driven inflammation in the oral mucosa and dental
pulp. The recent identification of spatial interactions between
nerves and both mast cells and LC in a neural-immune net-
work opens new possibilities for altering the function of these
critical immune cells.
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